Warning letters, 483s, Recalls, Import Alerts, Audit observations
Indian drug regulator, Central Drugs Standard Control Organisation (CDSCO) has issued new directions for stringent
Government of India is amending the New Drugs and Clinical Trials (NDCT) Rules 2019 permitting
Government of India has published the Gazette notification to make disclosure of Qualitative details of
Indian drug regulator CDSCO has published the Not of Standard Quality (NSQ) alert lists for
Indian regulatory agency, CDSCO has updated the requirements for application and issuance of Export NOC
The Drugs Technical Advisory Board (DTAB) in India has recommended for amendment of Drug Rules
Health Ministry in India has extended the timeline for implementation of the revised Schedule M
The Central Drugs Standard Control Organization (CDSCO) has issued a spurious drug alert for popular
CDSCO has published an update on the Spurious and Misbranded drugs in September 2024. Medicinal
CDSCO has published alert of list of drugs Not of Standard Quality (NSQ) identified during
